Willow Biosciences Inc. (CANSF)
- Previous Close
0.0635 - Open
0.0611 - Bid --
- Ask --
- Day's Range
0.0611 - 0.0637 - 52 Week Range
0.0490 - 0.1080 - Volume
25,000 - Avg. Volume
18,825 - Market Cap (intraday)
8.365M - Beta (5Y Monthly) 1.07
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0700 - Earnings Date May 9, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
2.00
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation. Willow Biosciences Inc. is headquartered in Calgary, Canada.
www.willowbio.com19
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: CANSF
Performance Overview: CANSF
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CANSF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CANSF
Valuation Measures
Market Cap
8.37M
Enterprise Value
7.63M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.26
Price/Book (mrq)
3.23
Enterprise Value/Revenue
6.51
Enterprise Value/EBITDA
-0.69
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-67.87%
Return on Equity (ttm)
-131.54%
Revenue (ttm)
1.17M
Net Income Avi to Common (ttm)
-13.03M
Diluted EPS (ttm)
-0.0700
Balance Sheet and Cash Flow
Total Cash (mrq)
3.78M
Total Debt/Equity (mrq)
62.75%
Levered Free Cash Flow (ttm)
-6.23M
Research Analysis: CANSF
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: CANSF
CANSF does not have Company Insights